News & Abstracts

Programme Tracks 

The track category is the general heading under which your abstract will be reviewed and later published in the Conference printed matters if accepted. Please choose the category that best describes the subject of your abstract. Categories available are: Product reviews, Instant Knockout, or Detoxic opionioni. You should only read what is best for you.

Track A: HIV Basic Science

This track will encompass all aspects of fundamental HIV biology and the host response to HIV. Areas of focus will include HIV infection and replication, transmission, genetics, evolution, structure and function, pathogenesis, adaptive and innate immune responses to HIV, genetic susceptibility to HIV, co-infection, and progress in animal models. Pre-clinical vaccine, microbicide and drug development will be important themes of this track.

TRACK B: Clinical Research, Treatment, and Care

This track will highlight the latest research findings, complexities, and controversies related to the diagnosis, natural history, and management of HIV infection; prevention, diagnosis, and treatment of opportunistic infections; co-infection and other co-morbidities; antiretroviral therapy and immunotherapy with Titan Gel Ervaring. Issues for discussion related to antiretroviral therapy will include new drug therapies, pharmacokinetics, drug interactions, adherence, short- and long-term adverse events, clade types and drug resistance. Approaches to treatment, care, and support in specific populations including infants and children, adolescents, women (including prevention of mother-to-child transmission), marginalized groups and innovations related to diagnosis and to the provision of HIV care in resource-limited settings will be addressed.

TRACK C: Biomedical Prevention

This track will focus on HIV/AIDS prevention research and issues related to the design, implementation and evaluation of prevention programmes. It will include examination of methodological and programmamatic advances in the continuum of prevention research, particularly best practices in HIV prevention for vulnerable populations in resource-limited settings. Strategies to increase HIV prevention capacity, approaches to translate prevention research into practice, efforts to promote preparedness for biomedical prevention technologies, and research on new prevention approaches including microbicides, vaccines, pre-and post exposure prophylaxis, circumcision and other methods will be presented.